Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Katkin Keith
Relationship:   Director
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   1,258,490    

Indirect Shares

   0      
Direct Value   $4,827,703    

Indirect Value

   $0      
Total Shares   1,258,490      
Total Value   $4,827,703      


Avanir Pharmaceuticals $0 Eledon Pharmaceuticals Ord Shs $34,176 Urovant Sciences Ltd. $3,242,803 Syndax Pharmaceuticals Inc $1,318,200 Rigel Pharmaceuticals Inc $30,500 Emergent Biosolutions Inc. $202,024 Avanir Pharmaceuticals $0 Eledon Pharmaceuticals Ord Shs $34,176 Urovant Sciences Ltd. $3,242,803 Syndax Pharmaceuticals Inc $1,318,200 Rigel Pharmaceuticals Inc $30,500 Emergent Biosolutions Inc. $202,024
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Avanir Pharmaceuticals AVNR President and CEO, Dir... 2014-12-17 914,249 2006-05-25 0    Premium*  
            Eledon Pharmaceuticals Ord Shs ELDN Director 2017-05-10 12,119 0    Premium*  
            Urovant Sciences Ltd. UROV PEO;CEO/Urovant Scienc... 2020-02-19 199,680 2019-12-09 0    Premium*  
            Syndax Pharmaceuticals Inc SNDX 2024-02-07 65,000 2021-02-03 0    Premium*  
            Rigel Pharmaceuticals Inc RIGL Director 2021-05-19 25,000 2021-05-19 0    Premium*  
            Emergent Biosolutions Inc. EBS Director 2023-05-25 42,442 2022-04-02 0    Premium*  
* Premium Members only  

Records found :    76         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2012-12-03 4 AS $2.55 $46,457 D/D (18,250) 119,482 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2013-05-15 4 AS $3.26 $816,313 D/D (250,438) 495,107 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2013-08-02 4 AS $4.84 $74,981 D/D (15,500) 479,607 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2013-11-01 4 AS $4.14 $18,138 D/D (4,385) 475,222 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2013-12-18 4 AS $2.67 $78,935 D/D (29,515) 445,707 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2014-05-28 4 AS $5.01 $2,215,482 D/D (442,212) 750,082 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2014-08-01 4 AS $5.26 $50,864 D/D (9,670) 760,412 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2014-10-24 4 AS $11.76 $324,188 D/D (27,567) 732,845 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2014-12-15 4 AS $16.95 $3,646,962 D/D (215,160) 976,769 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2014-12-17 4 AS $16.93 $1,058,464 D/D (62,520) 914,249 0 -
UROV Urovant Sciences Ltd. PEO;CEO/Urovant Sciences, Inc.   •       •      –    2019-12-09 4 AS $12.78 $1,533,600 D/D (120,000) 0 0 -
SNDX Syndax Pharmaceuticals In...   –       •      –    2022-09-30 4 AS $25.07 $89,277 D/D (3,561) 32,000 0 %
SNDX Syndax Pharmaceuticals In...   –       •      –    2022-10-03 4 AS $25.00 $4,500 D/D (180) 32,000 0 %
SNDX Syndax Pharmaceuticals In...   –       •      –    2022-10-04 4 AS $25.00 $9,000 D/D (360) 32,000 0 %
SNDX Syndax Pharmaceuticals In...   –       •      –    2022-10-06 4 AS $25.90 $774,411 D/D (29,899) 32,000 0 %
AVNR Avanir Pharmaceuticals Sr. V.P. of Sales & Marketing   •       –      –    2006-05-25 4 B $8.98 $22,484 D/D 2,500 2,500 2.74 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2009-02-24 4 B $0.43 $6,591 D/D 15,000 593,442 2.81 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2012-03-06 4 B $2.61 $26,093 D/D 10,000 327,857 2.81 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2007-12-13 4 D $1.66 $8,546 D/D (5,148) 581,268 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2008-03-13 4 D $1.10 $1,693 D/D (1,539) 579,729 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2008-06-13 4 D $1.11 $1,429 D/D (1,287) 578,442 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2009-06-13 4 D $1.31 $1,686 D/D (1,287) 592,155 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2009-07-15 4 D $2.13 $100,197 D/D (47,041) 545,114 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2009-09-13 4 D $2.21 $2,844 D/D (1,287) 543,827 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2009-12-13 4 D $1.82 $2,402 D/D (1,320) 542,507 0 -
  76  Records found
  1   2  3   4      
  Page 2 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us